Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

ABOUT THE FOUNDATION
PANCREATIC CANCER
RESEARCH
PATIENTS & CAREGIVERS
HOW YOU CAN HELP
SEARCH

Home / News / Threshold Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2 Trials for the Treatment of Pancreatic Cancer

Threshold Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2 Trials for the Treatment of Pancreatic Cancer

Press Release

September 14, 2006

Press Release

Filed Under: News, Research

Editorial recognizes Dr, Howard Reber MD, Director of the Hirshberg Translational Laboratory and Professor of Surgery and Chief of Gastrointestinal Surgery at UCLA

Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half

Patient Support Resources

from the comfort of your home

Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »

SUBSCRIBE

Our Free E-Newsletter

Sign up to receive information on breaking news, patient programs and upcoming events.

You can custom tailor your subscriptions and unsubscribe at any time.

How You Can Help
Make A Donation
Host an Event
Shop Online Store

Signature Events
L.A. Cancer Challenge
Tour De Pier
Hirshberg Training Team

More
News
Press
Contact

Stay Connected

Join Our E-newsletter

Legal and Privacy
Financial Information
Contact